Superior Processing System

CBR's CellAdvantage™ cord blood processing system uses automation technology developed by ThermoGenesis and distributed by GE Healthcare. The technology, called the AXP AutoXpress™ Platform (AXP™), is the industry's first functionally-closed, automated cord blood stem cell processing technology. Using this system, CBR anticipates meeting and exceeding its current cell recovery rate of 99 percent, which is the highest published cell recovery rate in the industry.

Full Cell Separation - For the Best Transplant Results

Cord Blood Registry's unique cell separation methods improve the viability and usability of samples when compared to other methods of cell processing. Our methods were thoroughly researched before storing samples for our clients and have been continually improved over the last decade. CBR's lab director, Dr. David T. Harris, has published data regarding our processing methods and results in several medical journals. Our published results show that our methods routinely recover more than 99 percent of the original mononuclear cell population. CBR's lab has over ten years of experience performing this highly specialized procedure for thousands of clients - an achievement unrivaled in this industry.

Click here to learn about our secure storage facilty.

ThermoGenesis©,Autoxpress™ , and AXP™ are registered trademarks of ThermoGenisis Corp., Sepax is a registered trademark of Biosafe SA. Viacord is a registered trademark of ViaCell,Inc